Uptick Newswire talks with Dr. David Summers

Released on October 25, 2016, Uptick Newswire’s Jasyn Blair interviewed Dr. Dr. David Summers, AngioSoma, Inc.’s Chairman Emeritus (entitled “Dr. David Summers, AngioSoma Inc., Talks Entering Joint Venture to Commercialize their Signature Product“.  We also make it available here: Other media outlets covering the interview… Investors Hangout (Front Page) iTunes iHeartRADIO Google Play Audio Boom! Read more about Uptick Newswire talks with Dr. David Summers[…]

AngioSoma, Inc. Announces a Liprostin™ Focused Joint Venture

MONTGOMERY, Texas–(BUSINESS WIRE)–AngioSoma, Inc. (OTCQB:SOAN) announces a joint venture with La Jolla Capital Partners LLC (‘La Jolla’) focused on the funding and management of US Food and Drug Administration (‘FDA’) Liprostin™ Phase III trials, as well as the licensing of Liprostin™ worldwide thereafter. Liprostin™ is a liposomal encapsulated prostaglandin e1 (‘PGE1’) and is AngioSoma, Inc.’s Read more about AngioSoma, Inc. Announces a Liprostin™ Focused Joint Venture[…]